Laurus Bio
Laurus Bio is an integrated research-driven biomanufacturing organization specializing in precision fermentation and recombinant DNA technology. It develops and manufactures ultra-pure animal-free recombinant proteins, growth factors, and cell-culture media supplements for biopharma, food, health, and nutrition markets. The company offers CDMO services across the microbial fermentation value chain, supporting clients from clone development to large-scale manufacturing. With a focus on safety, sustainability, and quality, Laurus Bio aims to replace animal-derived products and promote a global shift towards more sustainable biotechnological solutions.
Industries
Nr. of Employees
medium (51-250)
Products
Recombinant insulin-like growth factor (IGF1-LR3)
Recombinant IGF1-LR3 analogue produced in E. coli intended as a growth factor for cell proliferation and large-scale cell-culture applications; supplied as liquid or powder with defined purity, endotoxin, and bioassay specifications.
Recombinant Carboxypeptidase B
Recombinant exoprotease (~34.5 kDa) expressed in Pichia pastoris for sequence analysis, API manufacturing (e.g., insulin), and antibody quality control; available as liquid or powder with activity and purity specifications.
Recombinant human albumin (10% and 20% formulations)
Recombinant human albumin produced in Pichia pastoris for cell-culture, diagnostic, therapeutic, and industrial uses; provided as liquid formulations with defined protein concentration, high purity, and low endotoxin.
Recombinant epidermal growth factor (EGF)
Recombinant EGF expressed in E. coli supplied as liquid or powder with characterized molecular weight, purity, low endotoxin, and bioassay potency; intended for serum-free media and analytical standards.
Additional recombinant enzymes and cell-culture supplements
A portfolio of microbial fermentation-derived recombinant products including proteases (trypsin, thermolysin), transferrin, fibroblast growth factor (FGFb), and other growth factors and supplements for cell culture and manufacturing.
Recombinant insulin-like growth factor (IGF1-LR3)
Recombinant IGF1-LR3 analogue produced in E. coli intended as a growth factor for cell proliferation and large-scale cell-culture applications; supplied as liquid or powder with defined purity, endotoxin, and bioassay specifications.
Recombinant Carboxypeptidase B
Recombinant exoprotease (~34.5 kDa) expressed in Pichia pastoris for sequence analysis, API manufacturing (e.g., insulin), and antibody quality control; available as liquid or powder with activity and purity specifications.
Recombinant human albumin (10% and 20% formulations)
Recombinant human albumin produced in Pichia pastoris for cell-culture, diagnostic, therapeutic, and industrial uses; provided as liquid formulations with defined protein concentration, high purity, and low endotoxin.
Recombinant epidermal growth factor (EGF)
Recombinant EGF expressed in E. coli supplied as liquid or powder with characterized molecular weight, purity, low endotoxin, and bioassay potency; intended for serum-free media and analytical standards.
Additional recombinant enzymes and cell-culture supplements
A portfolio of microbial fermentation-derived recombinant products including proteases (trypsin, thermolysin), transferrin, fibroblast growth factor (FGFb), and other growth factors and supplements for cell culture and manufacturing.
Services
Microbial precision fermentation CDMO services
Contract development and manufacturing services covering clone development, strain engineering, bioprocess development, fermentation scale-up from R&D/bench to pilot, and large-scale commercial manufacturing for recombinant proteins and enzymes.
Microbial precision fermentation CDMO services
Contract development and manufacturing services covering clone development, strain engineering, bioprocess development, fermentation scale-up from R&D/bench to pilot, and large-scale commercial manufacturing for recombinant proteins and enzymes.
Expertise Areas
- Precision fermentation
- Recombinant protein production (microbial systems)
- CDMO for microbial fermentation
- Bioprocess development and scale-up
Key Technologies
- Precision fermentation
- Recombinant expression in Escherichia coli
- Recombinant expression in Pichia pastoris
- Strain engineering